CURRICULUM VITAE Luigi Cubeddu PERSONAL - College of ...

LUIGI X. CUBEDDU
83.Faggin, B.M., Zubieta, J.K., Rezvani, A.H. and Cubeddu, L.X. Neurotensin-induced dopamine release in vivo and
in vitro from substantia nigra and nucleus caudate. J. Pharmacol. Exp. Ther. 252: 817-825, 1990.
84.Faggin, B.M. and Cubeddu, L.X. Rapid desensitization of dopamine release induced by neurotensin and
neurotensin fragments. J. Pharmacol. Exp. Ther. 253: 812-818, 1990.
85.Cubeddu, L.X., Hoffmann, I.S., Fuenmayor, N.T. and Finn, A.L. Antagonism of serotonin S3 receptors with
ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens. J Clin
Oncol 8: 1721-1727, 1990.
86.Cubeddu, L.X., Hoffmann, I.S., Fuenmayor, N.T. and Finn, A.L. Efficacy of ondansetron and the role of serotonin
in cisplatin-induced nausea and vomiting. Letter to the Editor. New England J. of Med. 323: 1991.
87.Cubeddu, L.X., Hoffmann, I.S., Fuenmayor, N.T. and Finn, A.L. Efficacy of ondansetron in cyclophosphamideinduced
nausea and vomiting. Letter to the Editor. J. Clin. Oncol. 1991.
88.Cubeddu, L.X., Hoffmann, I.S., Talmaciu, R.K., Diliberto, P. and Lovenberg, T. Carbachol Phorbol ester
interactions at muscarinic receptors modulating Dopamine release. Neuroscience Lett. 131: 245-248, 1991.
89.Cubeddu, L.X., Hoffmann, I.S., Fuenmayor, N.T. and Malave J. Changes in serotonin metabolism in cancer
patients: its relationships to nausea and vomiting induced by chemotherapeutic drugs. Brit. J. Cancer. 66:198-203,1992.
90.Buckley, J.W., Hedner, T., Masotto, C., Posvar, E., Negro-Vilar, A. and Cubeddu, L.X. Comparative effects of
verapamil on volume overload on atrial natriuretic factors and the renin-angiotensin-aldosterone-vasopressin system. J.
Clin. Pharmacol. 32:1120-1127, 1992.
91.Fuenmayor, N.T., Faggin B.M and Cubeddu L.X. Comparative efficacy, safety and kinetics of verapamil SR and IR
in hypertensive patients. Drugs. 44:Suppl. 1:1-11, 1992.
92. Cubeddu L.X. Mechanisms by which cancer chemotherapeutic drugs induce emesis. Seminars in Oncology. 19:2-
13, 1992.
93. Cubeddu L.X., Hoffmann I.S. and Fuenmayor N.T. Serotonin and Emesis- from animals to humans. Brit J Cancer.
66:suppl XIX:S9-S11, 1992.
94. Cubeddu LX. Receptores serotonérgicos 5-HT3: papel en las náuseas y vómitos asociados a la quimioterapía
antineoplásica. Revista de Farmacología Clinica y Experimental. Special Number. 107-109, 1992.
95. Beck T.M., Cubeddu L.X., Hainsworth J., Hesketh P.J., Bryson J.C., Scarantino C.W. and Berry W.R. Serotoninmediated
emesis: the role of ondansetron. Seminars in Oncology. 19:44-46, 1992.
96. Cubeddu, L.X.,and Hoffmann, I.S. Participation of serotonin on early and delayed emesis induced by initial and
subsequent cycles of cisplatinum-based chemotherapy: effects of dexamethasone and metoclopramide. J Clin
Pharmacol.33: 691-697, 1993.
97. Cubeddu, L.X., Pendergrass,K., Thomas, R., Martin, Y., Burton, G., Meshad, M., Galvin, D. and Ciociola, A.A.
Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting
associated with cyclophosphamide-based chemotherapies. Am J Clin Oncol. 17: 137-146, 1994
98. Alfieri B.A. and Cubeddu L.X. Changes in urinary 5-HIAA excretion induced by dietary manipulations in man.
J.Clin. Pharmacol. 34:153-157,1994.
99. Agneter, E., Hoffmann, I.S., Cubeddu, L.X. and Singer, E. Behavior of mesocortical dopamine terminals during
single and repetitive stimulation: comparison with nigrostriatal neurons. J. Pharmacol Exp Ther. 269:470-476;1994.
13